Anodyne| Ciclotizolam | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Conformer [] | |
|---|---|
| Conformer structure via JSmol | |
| Physical properties [] | |
|---|---|
| Molecular mass | 461.8 g/mol [1] |
| Predicted LogP | 4.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C20H18BrClN4S [1] |
| IUPAC name | 4-bromo-7-(2-chlorophenyl)-13-cyclohexyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene [1] |
| SMILES | C1CCC(CC1)C2=NN=C3N2C4=C(C=C(S4)Br)C(=NC3)C5=CC=CC=C5Cl [1] |
| InChI | InChI=1S/C20H18BrClN4S/c21-16-10-14-18(13-8-4-5-9-15(13)22)23-11-17-24-25-19(26(17)20(14)27-16)12-6-2-1-3-7-12/h4-5,8-10,12H,1-3,6-7,11H2 [1] |
| InChIKey | ZOSHXIXUCKESEG-UHFFFAOYSA-N [1] |
Ciclotizolam
Ciclotizolam (also known as We 973-BS, Ciclotizolamum, We 973, WE-973-BS, 2-Bromo-4-(o-chlorophenyl)-9-cyclohexyl-6H-thieno(3,2-f)-s-triazolo(4,3-a)(1,4)diazepine, WE-973 or HY-168363) is a
Chemistry
Stereochemistry []
Ciclotizolam is a achiral mixture
Legal status
- Canada: Ciclotizolam is a Schedule IV substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 71949, Ciclotizolam. Accessed June 26, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/71949
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ciclotizolam. UNII: JK517QTN4Q. Global Substance Registration System. Accessed June 26, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/JK517QTN4Q